Paper698935
Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
Heppner GH and 4 others. Cancer Res, 1978. Cited by 295 papers, by iCite.
Cite this record
ConductScience Library. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Papers, record 698935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/698935
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antineoplastic Agents | Major topic |
| Mammary Neoplasms, Experimental | Major topic |
| Animals | |
| Cell Line | |
| Cyclophosphamide | |
| Drug Resistance | |
| Fluorouracil | |
| Male | |
| Methotrexate | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C3H | |
| Neoplasm Metastasis | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42293745 | Metabolic reprogramming and plasticity of cancer stem cells. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42293745 | PubMed |
| 42193921 | Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects. | Cells | 2026 | https://conductscience.org/library/papers/42193921 | PubMed |
| 40759634 | Cancer stem cells: landscape, challenges and emerging therapeutic innovations. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40759634 | PubMed |
| 39337633 | Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine-Trastuzumab Conjugate. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337633 | PubMed |
| 38435793 | Relatively Rare Populations of Invasive Cells Drive Progression of Heterogeneous Tumors. | Cell Mol Bioeng | 2024 | https://conductscience.org/library/papers/38435793 | PubMed |
| 34473289 | Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model. | J Pharm Pharmacol | 2021 | https://conductscience.org/library/papers/34473289 | PubMed |
| 33959849 | Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. | Cancer Metastasis Rev | 2021 | https://conductscience.org/library/papers/33959849 | PubMed |
| 32195244 | In vitro Models of Breast Cancer Metastatic Dormancy. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32195244 | PubMed |
| 31783695 | Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31783695 | PubMed |
| 31623133 | The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind? | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31623133 | PubMed |
| 31597954 | HUNK phosphorylates EGFR to regulate breast cancer metastasis. | Oncogene | 2020 | https://conductscience.org/library/papers/31597954 | PubMed |
| 31205572 | BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. | J Cancer | 2019 | https://conductscience.org/library/papers/31205572 | PubMed |
| 29732370 | Microenvironmental Signals and Biochemical Information Processing: Cooperative Determinants of Intratumoral Plasticity and Heterogeneity. | Front Cell Dev Biol | 2018 | https://conductscience.org/library/papers/29732370 | PubMed |
| 29218910 | Pan-cancer analysis of expressed somatic nucleotide variants in long intergenic non-coding RNA. | Pac Symp Biocomput | 2018 | https://conductscience.org/library/papers/29218910 | PubMed |
| 29123422 | Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding. | Cancer Growth Metastasis | 2017 | https://conductscience.org/library/papers/29123422 | PubMed |
| 27751894 | Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche. | Biochim Biophys Acta | 2016 | https://conductscience.org/library/papers/27751894 | PubMed |
| 27228477 | Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip. | Mol Pharm | 2016 | https://conductscience.org/library/papers/27228477 | PubMed |
| 26305796 | Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq. | PLoS One | 2015 | https://conductscience.org/library/papers/26305796 | PubMed |
| 26175968 | Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer. | Front Oncol | 2015 | https://conductscience.org/library/papers/26175968 | PubMed |
| 25962957 | Endogenous molecular network reveals two mechanisms of heterogeneity within gastric cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/25962957 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/698935
GET https://conductscience.org/api/papers/v1/698935/cited_by?page=2